13D/13G Filings - AH Bio Fund II L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-11-17
06:00 am
Sale
2023-11-09 13D EQRx, Inc.
EQRX
AH Bio Fund II L.P. 0
0.000%
-53,064,157decrease
(Position Closed)
Filing
History
2021-12-27
4:31 pm
Purchase
2021-12-17 13D EQRx, Inc.
EQRX
AH Bio Fund II L.P. 53,064,157
10.900%
53,064,157increase
(New Position)
Filing
History
2021-06-30
2:26 pm
Purchase
2021-06-09 13D Nautilus Biotechnology, Inc.
NAUT
AH Bio Fund II L.P. 17,653,917
14.200%
17,653,917increase
(New Position)
Filing
History